Stem definition | Drug id | CAS RN |
---|---|---|
local anaesthetics | 323 | 94-09-7 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Methaemoglobinaemia | 258.36 | 25.04 | 58 | 6145 | 1984 | 50596937 |
Irritable bowel syndrome | 183.39 | 25.04 | 100 | 6103 | 51341 | 50547580 |
Helicobacter infection | 140.35 | 25.04 | 83 | 6120 | 49619 | 50549302 |
Ill-defined disorder | 130.55 | 25.04 | 82 | 6121 | 54572 | 50544349 |
Pericarditis | 130.24 | 25.04 | 94 | 6109 | 78595 | 50520326 |
Muscle injury | 118.08 | 25.04 | 67 | 6136 | 37044 | 50561877 |
Folliculitis | 117.28 | 25.04 | 68 | 6135 | 39157 | 50559764 |
Blister | 116.77 | 25.04 | 91 | 6112 | 85327 | 50513594 |
Contusion | 108.79 | 25.04 | 98 | 6105 | 112085 | 50486836 |
Duodenal ulcer perforation | 95.44 | 25.04 | 63 | 6140 | 45548 | 50553373 |
Arthropathy | 89.11 | 25.04 | 103 | 6100 | 157803 | 50441118 |
Discomfort | 84.60 | 25.04 | 84 | 6119 | 108296 | 50490625 |
Impaired healing | 83.90 | 25.04 | 69 | 6134 | 69717 | 50529204 |
Hepatic enzyme increased | 73.11 | 25.04 | 87 | 6116 | 137293 | 50461628 |
Completed suicide | 70.96 | 25.04 | 84 | 6119 | 131805 | 50467116 |
Drug abuse | 69.47 | 25.04 | 58 | 6145 | 59788 | 50539133 |
Stomatitis | 69 | 25.04 | 73 | 6130 | 101271 | 50497650 |
Anti-cyclic citrullinated peptide antibody positive | 67.01 | 25.04 | 61 | 6142 | 70526 | 50528395 |
Sleep disorder due to general medical condition, insomnia type | 64.69 | 25.04 | 43 | 6160 | 31404 | 50567517 |
Lower respiratory tract infection | 63.78 | 25.04 | 68 | 6135 | 95133 | 50503788 |
Gastrointestinal disorder | 62.45 | 25.04 | 67 | 6136 | 94389 | 50504532 |
Hypersensitivity | 61.44 | 25.04 | 101 | 6102 | 215060 | 50383861 |
Synovitis | 55.51 | 25.04 | 72 | 6131 | 123793 | 50475128 |
Rheumatoid factor positive | 53.09 | 25.04 | 46 | 6157 | 49813 | 50549108 |
Systemic lupus erythematosus | 52.79 | 25.04 | 75 | 6128 | 140547 | 50458374 |
Hand deformity | 49.24 | 25.04 | 61 | 6142 | 100138 | 50498783 |
Toxicity to various agents | 46.73 | 25.04 | 89 | 6114 | 212410 | 50386511 |
Swelling | 45.23 | 25.04 | 85 | 6118 | 200787 | 50398134 |
Glossodynia | 43.88 | 25.04 | 62 | 6141 | 115507 | 50483414 |
Pemphigus | 42.02 | 25.04 | 62 | 6141 | 120104 | 50478817 |
Confusional state | 41.01 | 25.04 | 78 | 6125 | 185850 | 50413071 |
Wound | 40.52 | 25.04 | 57 | 6146 | 105737 | 50493184 |
Infection | 39.93 | 25.04 | 74 | 6129 | 172880 | 50426041 |
Respiratory arrest | 38.82 | 25.04 | 31 | 6172 | 29978 | 50568943 |
Abdominal discomfort | 37.97 | 25.04 | 86 | 6117 | 231555 | 50367366 |
Alopecia | 35.82 | 25.04 | 87 | 6116 | 244960 | 50353961 |
Pruritus | 35.57 | 25.04 | 95 | 6108 | 283473 | 50315448 |
Nasopharyngitis | 33.13 | 25.04 | 73 | 6130 | 192854 | 50406067 |
Cyanosis | 29.38 | 25.04 | 20 | 6183 | 15164 | 50583757 |
Nausea | 28.33 | 25.04 | 27 | 6176 | 705371 | 49893550 |
Infusion related reaction | 26.69 | 25.04 | 62 | 6141 | 169495 | 50429426 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Drug abuse | 273.11 | 21.94 | 136 | 2548 | 79747 | 29492096 |
Methaemoglobinaemia | 175.07 | 21.94 | 42 | 2642 | 2629 | 29569214 |
Intentional product misuse | 151.16 | 21.94 | 70 | 2614 | 34591 | 29537252 |
Toxicity to various agents | 125.15 | 21.94 | 112 | 2572 | 173549 | 29398294 |
Serotonin syndrome | 84.46 | 21.94 | 38 | 2646 | 17474 | 29554369 |
Completed suicide | 82.66 | 21.94 | 67 | 2617 | 90179 | 29481664 |
Respiratory arrest | 67.65 | 21.94 | 37 | 2647 | 25796 | 29546047 |
Hangover | 42.14 | 21.94 | 11 | 2673 | 966 | 29570877 |
Intentional overdose | 35.97 | 21.94 | 29 | 2655 | 38499 | 29533344 |
Mydriasis | 35.12 | 21.94 | 15 | 2669 | 6070 | 29565773 |
Cardiac arrest | 31.88 | 21.94 | 39 | 2645 | 85552 | 29486291 |
Cardio-respiratory arrest | 31.02 | 21.94 | 30 | 2654 | 50571 | 29521272 |
Overdose | 25.95 | 21.94 | 34 | 2650 | 79785 | 29492058 |
Paranoia | 22.69 | 21.94 | 13 | 2671 | 9864 | 29561979 |
Rebound effect | 22.36 | 21.94 | 8 | 2676 | 2023 | 29569820 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Methaemoglobinaemia | 400.94 | 21.18 | 93 | 6797 | 4255 | 64487587 |
Drug abuse | 333.21 | 21.18 | 195 | 6695 | 132179 | 64359663 |
Toxicity to various agents | 157.05 | 21.18 | 193 | 6697 | 363320 | 64128522 |
Intentional product misuse | 144.18 | 21.18 | 92 | 6798 | 72203 | 64419639 |
Completed suicide | 142.84 | 21.18 | 146 | 6744 | 224268 | 64267574 |
Irritable bowel syndrome | 112.30 | 21.18 | 62 | 6828 | 37307 | 64454535 |
Respiratory arrest | 107.00 | 21.18 | 68 | 6822 | 52917 | 64438925 |
Helicobacter infection | 84.38 | 21.18 | 52 | 6838 | 38310 | 64453532 |
Pericarditis | 80.83 | 21.18 | 61 | 6829 | 62455 | 64429387 |
Systemic lupus erythematosus | 69.23 | 21.18 | 61 | 6829 | 77551 | 64414291 |
Sleep disorder due to general medical condition, insomnia type | 69.19 | 21.18 | 40 | 6850 | 26230 | 64465612 |
Stomatitis | 63.57 | 21.18 | 68 | 6822 | 109537 | 64382305 |
Arthropathy | 61.43 | 21.18 | 70 | 6820 | 120897 | 64370945 |
Contusion | 59.65 | 21.18 | 67 | 6823 | 113898 | 64377944 |
Ill-defined disorder | 59.18 | 21.18 | 44 | 6846 | 44008 | 64447834 |
Discomfort | 57.47 | 21.18 | 56 | 6834 | 80822 | 64411020 |
Blister | 57.41 | 21.18 | 56 | 6834 | 80911 | 64410931 |
Synovitis | 56.61 | 21.18 | 61 | 6829 | 99029 | 64392813 |
Serotonin syndrome | 52.23 | 21.18 | 39 | 6851 | 39243 | 64452599 |
Cardiac arrest | 50.95 | 21.18 | 72 | 6818 | 153992 | 64337850 |
Cyanosis | 46.09 | 21.18 | 29 | 6861 | 22126 | 64469716 |
Cardio-respiratory arrest | 45.02 | 21.18 | 54 | 6836 | 98339 | 64393503 |
Rheumatoid factor positive | 44.92 | 21.18 | 34 | 6856 | 34904 | 64456938 |
Muscle injury | 43.77 | 21.18 | 30 | 6860 | 26407 | 64465435 |
Folliculitis | 42.54 | 21.18 | 31 | 6859 | 30046 | 64461796 |
Swelling | 41.73 | 21.18 | 67 | 6823 | 160151 | 64331691 |
Intentional overdose | 40.55 | 21.18 | 49 | 6841 | 89895 | 64401947 |
Sleep disorder | 39.90 | 21.18 | 40 | 6850 | 59669 | 64432173 |
Duodenal ulcer perforation | 38.66 | 21.18 | 31 | 6859 | 34594 | 64457248 |
Wound | 38.35 | 21.18 | 44 | 6846 | 76433 | 64415409 |
Sudden infant death syndrome | 34.66 | 21.18 | 7 | 6883 | 164 | 64491678 |
Hepatic enzyme increased | 33.36 | 21.18 | 54 | 6836 | 129889 | 64361953 |
Hangover | 33.13 | 21.18 | 11 | 6879 | 1890 | 64489952 |
Hypersensitivity | 31.92 | 21.18 | 67 | 6823 | 196385 | 64295457 |
Overdose | 28.97 | 21.18 | 57 | 6833 | 159509 | 64332333 |
Medication error | 27.18 | 21.18 | 30 | 6860 | 49936 | 64441906 |
Impaired healing | 25.71 | 21.18 | 32 | 6858 | 60441 | 64431401 |
Anti-cyclic citrullinated peptide antibody positive | 25.65 | 21.18 | 29 | 6861 | 49533 | 64442309 |
Injection site ulcer | 25.19 | 21.18 | 7 | 6883 | 660 | 64491182 |
Mydriasis | 24.45 | 21.18 | 17 | 6873 | 15295 | 64476547 |
Alopecia | 24.03 | 21.18 | 54 | 6836 | 165636 | 64326206 |
Abdominal discomfort | 23.79 | 21.18 | 57 | 6833 | 182265 | 64309577 |
Glossodynia | 22.48 | 21.18 | 31 | 6859 | 64665 | 64427177 |
Pemphigus | 22.48 | 21.18 | 30 | 6860 | 60671 | 64431171 |
Accidental overdose | 21.53 | 21.18 | 22 | 6868 | 33535 | 64458307 |
None
Source | Code | Description |
---|---|---|
ATC | C05AD03 | CARDIOVASCULAR SYSTEM VASOPROTECTIVES AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Local anesthetics |
ATC | D04AB04 | DERMATOLOGICALS ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. Anesthetics for topical use |
ATC | N01BA05 | NERVOUS SYSTEM ANESTHETICS ANESTHETICS, LOCAL Esters of aminobenzoic acid |
ATC | R02AD01 | RESPIRATORY SYSTEM THROAT PREPARATIONS THROAT PREPARATIONS Anesthetics, local |
FDA CS | M0000728 | Allergens |
MeSH PA | D000777 | Anesthetics |
MeSH PA | D000779 | Anesthetics, Local |
MeSH PA | D002491 | Central Nervous System Agents |
MeSH PA | D002492 | Central Nervous System Depressants |
MeSH PA | D018373 | Peripheral Nervous System Agents |
MeSH PA | D018689 | Sensory System Agents |
FDA PE | N0000175629 | Increased Histamine Release |
FDA PE | N0000184306 | Cell-mediated Immunity |
FDA EPC | N0000185508 | Standardized Chemical Allergen |
CHEBI has role | CHEBI:48425 | topical anesthetic |
CHEBI has role | CHEBI:50904 | alergeno |
CHEBI has role | CHEBI:59683 | antipruritic drugs |
CHEBI has role | CHEBI:139492 | sensitizers |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Tinea pedis | indication | 6020002 | DOID:12403 |
Cough | indication | 49727002 | |
Tinea corporis | indication | 84849002 | |
Sore throat symptom | indication | 267102003 | |
Skin irritation | indication | 367466007 | |
Local anesthesia | indication | 386761002 | |
Itching of skin | indication | 418363000 | |
Suppression of the Gag Reflex | indication | ||
Tinea Infections | indication | ||
Minor Skin Wound Pain | indication | ||
Mouth Irritation | indication | ||
Prevent Minor Bacterial Skin Infection | indication | ||
Hypocalcemia | off-label use | 5291005 | |
Otalgia | off-label use | 16001004 | |
Impacted cerumen | off-label use | 18070006 | |
Osteoporosis | off-label use | 64859006 | DOID:11476 |
Postmenopausal osteoporosis | off-label use | 102447009 | |
Indigestion | off-label use | 162031009 | |
Renal Osteodystrophy with Hyperphosphatemia | off-label use | ||
Gastritis | contraindication | 4556007 | DOID:4029 |
Suicidal thoughts | contraindication | 6471006 | |
Alcoholism | contraindication | 7200002 | |
Hyperammonemia | contraindication | 9360008 | |
Infectious gastroenteritis | contraindication | 12463005 | |
Hepatic encephalopathy | contraindication | 13920009 | DOID:13413 |
Constipation | contraindication | 14760008 | DOID:2089 |
Hypocupremia | contraindication | 19577007 | |
Herpes zoster auricularis | contraindication | 21954000 | DOID:9210 |
Sarcoidosis | contraindication | 31541009 | DOID:11335 |
Dehydration | contraindication | 34095006 | |
Depressive disorder | contraindication | 35489007 | |
Methemoglobinemia | contraindication | 38959009 | DOID:10783 |
Gastrointestinal ulcer | contraindication | 40845000 | |
Body fluid retention | contraindication | 43498006 | |
Conduction disorder of the heart | contraindication | 44808001 | |
Encephalitis | contraindication | 45170000 | DOID:9588 |
Disorder of cardiovascular system | contraindication | 49601007 | DOID:1287 |
Bleeding hemorrhoids | contraindication | 51551000 | |
Vitamin K deficiency | contraindication | 52675005 | DOID:11249 |
Nasal polyp | contraindication | 52756005 | |
Hepatic failure | contraindication | 59927004 | |
Perforation of tympanic membrane | contraindication | 60442001 | |
Diarrhea | contraindication | 62315008 | |
Blood coagulation disorder | contraindication | 64779008 | DOID:1247 |
Poisoning by phenobarbital | contraindication | 64921004 | |
Substance abuse | contraindication | 66214007 | |
Hypercalcemia | contraindication | 66931009 | DOID:12678 |
Hyperparathyroidism | contraindication | 66999008 | DOID:13543 |
Incontinence of feces | contraindication | 72042002 | |
Hepatic coma | contraindication | 72836002 | DOID:12550 |
Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
Sleep apnea | contraindication | 73430006 | DOID:0050847 |
Factor II deficiency | contraindication | 73975000 | |
Appendicitis | contraindication | 74400008 | DOID:8337 |
Gastrointestinal hemorrhage | contraindication | 74474003 | |
Thrombotic thrombocytopenic purpura | contraindication | 78129009 | DOID:10772 |
Decreased respiratory function | contraindication | 80954004 | |
Herpes simplex | contraindication | 88594005 | DOID:8566 |
Kidney disease | contraindication | 90708001 | DOID:557 |
Thyrotoxicosis | contraindication | 90739004 | DOID:7997 |
Hemophilia | contraindication | 90935002 | |
Diaper rash | contraindication | 91487003 | |
Disorder of skin | contraindication | 95320005 | DOID:37 |
Disorder of mucous membrane | contraindication | 95351003 | |
Kidney stone | contraindication | 95570007 | |
Anemia due to enzyme deficiency | contraindication | 111577008 | |
Deficiency of glucose-6-phosphate dehydrogenase | contraindication | 124134002 | DOID:2862 |
Deficiency of cytochrome-b>5< reductase | contraindication | 124184009 | |
Open wound | contraindication | 125643001 | |
Gastrointestinal obstruction | contraindication | 126765001 | |
Seizure disorder | contraindication | 128613002 | |
Tuberculosis of ear | contraindication | 186269001 | |
Osteolysis | contraindication | 203522001 | |
Gastroesophageal reflux disease | contraindication | 235595009 | DOID:8534 |
Disease of liver | contraindication | 235856003 | DOID:409 |
Disorder of electrolytes | contraindication | 237840007 | |
Dyspnea | contraindication | 267036007 | |
Anemia | contraindication | 271737000 | DOID:2355 |
Eruption of skin | contraindication | 271807003 | DOID:0050486 |
Pregnancy, function | contraindication | 289908002 | |
Thrombocytopenic disorder | contraindication | 302215000 | DOID:1588 |
Neutropenic disorder | contraindication | 303011007 | DOID:1227 |
Viral ear infection | contraindication | 312137007 | |
Fungal ear infection | contraindication | 312148000 | |
Infective otitis media | contraindication | 312218008 | |
Cardiovascular event risk | contraindication | 395112001 | |
Breastfeeding (mother) | contraindication | 413712001 | |
Denuded skin | contraindication | 418242004 | |
Porphyria | contraindication | 418470004 | |
Fever greater than 100.4 Fahrenheit | contraindication | 426000000 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 2.5 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Sodium channel protein type 1 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 2 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 3 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 4 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 8 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 9 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 11 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 10 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 7 subunit alpha | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||||
Sodium channel protein type 5 subunit alpha | Ion channel | BLOCKER | ED50 | 3.50 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE |
ID | Source |
---|---|
4018117 | VUID |
N0000146455 | NUI |
D00552 | KEGG_DRUG |
1049105 | RXNORM |
C0005059 | UMLSCUI |
CHEBI:116735 | CHEBI |
CHEMBL278172 | ChEMBL_ID |
DB01086 | DRUGBANK_ID |
D001566 | MESH_DESCRIPTOR_UI |
2337 | PUBCHEM_CID |
3953 | INN_ID |
23239-88-5 | SECONDARY_CAS_RN |
U3RSY48JW5 | UNII |
199 | MMSL |
359 | MMSL |
4256 | MMSL |
001366 | NDDF |
4018117 | VANDF |
387357002 | SNOMEDCT_US |
65020006 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
good sense vagicaineanti itch | HUMAN OTC DRUG LABEL | 2 | 0113-0142 | CREAM | 20 g | TOPICAL | OTC monograph not final | 13 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0220 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Gel | HUMAN OTC DRUG LABEL | 1 | 0283-0293 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Gel | HUMAN OTC DRUG LABEL | 1 | 0283-0293 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Gel | HUMAN OTC DRUG LABEL | 1 | 0283-0293 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0520 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Liquid | HUMAN OTC DRUG LABEL | 1 | 0283-0569 | LIQUID | 200 mg | DENTAL | OTC monograph not final | 12 sections |
HurriCaine | HUMAN OTC DRUG LABEL | 1 | 0283-0610 | SPRAY | 200 mg | DENTAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0679 | SPRAY | 200 mg | ORAL | OTC monograph not final | 11 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0871 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0871 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0871 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Gel | HUMAN OTC DRUG LABEL | 1 | 0283-0886 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Gel | HUMAN OTC DRUG LABEL | 1 | 0283-0886 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0914 | SPRAY | 200 mg | ORAL | OTC monograph not final | 11 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0920 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0998 | GEL | 200 mg | DENTAL | OTC monograph not final | 13 sections |
HurriCaineTopical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-0998 | GEL | 200 mg | DENTAL | OTC monograph not final | 13 sections |
HurriCaineTopical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-1016 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-1016 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Liquid | HUMAN OTC DRUG LABEL | 1 | 0283-1116 | LIQUID | 200 mg | DENTAL | OTC monograph not final | 12 sections |
HurriCaine Topical Anesthetic | HUMAN OTC DRUG LABEL | 1 | 0283-1820 | GEL | 200 mg | ORAL | OTC monograph not final | 12 sections |
HurriCaineTopical Anesthetic Liquid | HUMAN OTC DRUG LABEL | 1 | 0283-1886 | LIQUID | 200 mg | DENTAL | OTC monograph not final | 12 sections |
4x Medicated Toothache and Gum Cream | HUMAN OTC DRUG LABEL | 4 | 0363-0607 | CREAM | 20 g | ORAL | OTC monograph not final | 9 sections |
Anti-Itch Regular Strength | HUMAN OTC DRUG LABEL | 2 | 0363-0621 | CREAM | 5 g | TOPICAL | OTC monograph final | 11 sections |
Well at Walgreens Anti-Itch Maximum Strength | HUMAN OTC DRUG LABEL | 2 | 0363-0674 | CREAM | 20 g | TOPICAL | OTC monograph final | 11 sections |
Cherry Sore Throat Lozenge | HUMAN OTC DRUG LABEL | 2 | 0363-1079 | LOZENGE | 15 mg | ORAL | OTC monograph not final | 14 sections |
Mixed Berry Sore Throat and Cough Lozenge | HUMAN OTC DRUG LABEL | 2 | 0363-1080 | LOZENGE | 7.50 mg | ORAL | OTC monograph not final | 15 sections |
Walgreens Mixed Berry Benz-Dex Lozenges | HUMAN OTC DRUG LABEL | 2 | 0363-1113 | LOZENGE | 7.50 mg | ORAL | OTC monograph not final | 15 sections |
3x Medicated Mouth Sore Gel | HUMAN OTC DRUG LABEL | 3 | 0363-1605 | GEL | 20 g | ORAL | OTC monograph not final | 7 sections |